Renin-Angiotensin-Aldosterone System (RAAS) Blocker, Drug Exposure

Simple item page
dc.contributor.advisorUtidjian, Levon
dc.contributor.authorUtidjian, Levon
dc.contributor.otherChildren's Hospital of Philadelphia
dc.date.accessioned2024-09-26T13:58:54Z
dc.date.available2024-06-10T19:03:14Z
dc.date.created2021-03-01
dc.descriptionThis concept set identifies renin-angiotensin-aldosterone system-blocking medications including angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor blockers (ARBs), and other agents acting on the renin-angiotensin system. This medication concept set includes the following ingredients: aliskiren, azilsartan, benazepril, candesartan, captopril, cilazapril, enalapril, eprosartan, fosinopril, imidapril, irbesartan, lisinopril, losartan, moexipril, olmesartan, perindopril, quinapril, ramipril, spirapril, telmisartan, trandolapril, valsartan, and zofenopril. It also includes combinations of these ingredients with other antihypertensive medications. This code list was generated by taking the descendants of all the ACE, ARB, and other RAAS agent ingredients of interest, and string matching on the concept_name of the ingredient. Technical Note: This concept set was created when ingredients were required for some sites. It could be enhanced by using SCDF drug levels and taking descendants, making this easier to refresh. This concept set is identical to its predecessor, but it has been expanded to include RxNorm Extension codes in addition to RxNorm codes.
dc.description.abstractThis broad concept set was intended to identify patients who received angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor blockers (ARBs), and other agents acting on the renin-angiotensin system.
dc.identifier.urihttps://hdl.handle.net/20.500.14642/412.2
dc.identifier.urihttps://doi.org/10.24373/pdsp-299.2
dc.provenanceTreatment of Henoch-Schonlein purpura (HSP) Nephritis
dc.publisherPEDSnet
dc.relation.isreferencedbyStone HK, Mitsnefes M, Dickinson K, et al. 2023. "Clinical course and management of children with IgA vasculitis with nephritis." _Pediatr Nephrol_ 38, 3721-3733. <br>DOI: [10.1007/s00467-023-06023-8](https://doi.org/10.1007/s00467-023-06023-8)
dc.rightsa CC-BY Attribution 4.0 License.
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectBroad
dc.subject.meshVasoconstrictor
dc.subject.meshCardiovascular Agent
dc.subject.otherRxNorm
dc.subject.otherRxNorm Extension
dc.titleRenin-Angiotensin-Aldosterone System (RAAS) Blocker, Drug Exposure
dspace.entity.typeConceptSet
local.quality.statusNeeds Refinement
local.subject.DataModelPEDSnet Data Model
local.subject.EvalTypeClinician Reviewed
local.subject.MedTermCharBrand Pack Name
local.subject.MedTermCharSemantic Branded Drug
local.subject.MedTermCharSemantic Clinical Drug
local.subject.MedTermCharSemantic Branded Drug Form
local.subject.MedTermCharSemantic Clinical Drug Form
local.subject.MedTermCharSemantic Branded Drug Component
local.subject.MedTermCharSemantic Clinical Drug Component
local.subject.MedTermCharMultiple Ingredients
local.subject.MedTermCharPrecise Ingredient
local.subject.MedTermCharIngredient
local.variable.namerx_raas
relation.isStudyOfConceptSet9e8d04a8-d5be-4bd8-a904-c533a7dcd490
relation.isStudyOfConceptSet.latestForDiscovery9e8d04a8-d5be-4bd8-a904-c533a7dcd490

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
rx_2021_03_ReninAngioTensinAldosteronSystemBlockers_V2.csv
Size:
139.38 KB
Format:
Comma-Separated Values
Download

Domains

Medication Concept Sets

Version History

Now showing 1 - 2 of 2
VersionDateSummary
2*
 2024-09-26 09:56:15
Modified to include RXNorm Extension codes.
1
 2024-06-10 15:03:14
* Selected version